Vistara Bioscience
Biotechnology, 168 Third Ave, Woodbridge, Connecticut, 02451, United States, 1-10 Employees
Phone Number: +16*********
Who is VISTARA BIOSCIENCE
Vistara Bioscience is developing proteomics tools for drug discovery research in Targeted Protein Degradation (TPD) and other therapeutic modalities. Our TRIFECTA strategy is a combinatio...
Read More
-
Headquarters: 168 Third Ave, Woodbridge, Connecticut, 02451, United States
-
Date Founded: 2016
-
Employees: 1-10
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7372
|
NAICS Code: 513210 |
Show More
Does something look wrong? Fix it. | View contact records from VISTARA BIOSCIENCE
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding VISTARA BIOSCIENCE
Answer: VISTARA BIOSCIENCE's headquarters are located at 168 Third Ave, Woodbridge, Connecticut, 02451, United States
Answer: VISTARA BIOSCIENCE's phone number is +16*********
Answer: VISTARA BIOSCIENCE's official website is https://vistarabio.com
Answer: VISTARA BIOSCIENCE's revenue is $1 Billion and Over
Answer: VISTARA BIOSCIENCE's SIC: 7372
Answer: VISTARA BIOSCIENCE's NAICS: 513210
Answer: VISTARA BIOSCIENCE has 1-10 employees
Answer: VISTARA BIOSCIENCE is in Biotechnology
Answer: VISTARA BIOSCIENCE contact info: Phone number: +16********* Website: https://vistarabio.com
Answer: Vistara Bioscience is developing proteomics tools for drug discovery research in Targeted Protein Degradation (TPD) and other therapeutic modalities. Our TRIFECTA strategy is a combination of ubiquitomics, compound screening, and protein disruption processes for clinical applications in Oncology, Inflammation, and Neurodegeneration disease areas. Recent clinical outcomes in TPD have stressed the sobering reality that TPD solutions are not merely plug-and-play, rather have underscored the need for including more detailed information about the clinical target's proteostasis mechanisms into the TPD solution. Our global ubiquitome scanning technologies identify the similarities and differences between samples, and highlights the contextual information of target protein's proteostasis. These include protein networks, accessory factors, pathway components, and compound-induced changes of proteins which are in close collaboration with proteins of clinical interest. By combining our processes, design tools, and informatics, we design the choicest TPD solutions . The networks serve as biomarker panels to follow along the drug discovery process, and additionally, may suggest combinatorial targets or new ones.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month